Zeroing in on hepatic myofibroblasts while simultaneously addressing the underlying cause(s) of liver damage may be the key to reversing liver fibrosis. A new review by David Brenner, M.D., describes the emerging therapeutic approach.
An accomplished group of early-career researchers including postdoctoral scholars, graduate students and staff scientists showcased their work at Sanford Burnham Prebys’ 22nd Annual Trainee Research Symposium on Thursday, September 21st.
Svasti Haricharan, Ph.D., was the first guest on Stop & Talk—a new podcast offered by The Conrad Prebys Foundation. In the broadcast, Svasti shares how she came to be a research leader in therapy-resistant breast cancer and how race affects clinical outcomes.
Cosimo Commisso, Ph.D., has received a grant from the Department of Defense for $1 million to advance the research of a small molecule that kills pancreatic cancer cells by disrupting their pH equilibrium.
With the help of a new grant from the National Institutes of Health for more than $2.6 million, Assistant Professor Timothy Huang, Ph.D., will continue his research on the role of the brain’s immune cells on the risk of developing Alzheimer’s disease.
Sanford Burnham Prebys’ Cancer Center has received a rare and prestigious Merit Extension Award from the National Cancer Institute (NCI), recognizing and rewarding its earlier accomplishments as well as current research plans. The award extends the center’s current 5-year Cancer Center Support Grant (CCSG) for an additional two years.
New and rapidly developing technologies, such as cryo-electron (cryo-EM) and artificial intelligence, are providing the tools to revolutionize biomedical research, but you need scientists who know how to use them.
This month, researchers in Sweden published a study that compared the efficacy of artificial intelligence-supported mammogram screening versus the standard double reading by radiologists. Ze’ev Ronai, Ph.D. was interviewed.
Sanford Burnham Prebys welcomed its second cohort of SPARK interns this summer. SPARK is an initiative by the California Institute for Regenerative Medicine (CIRM) to provide research opportunities for high schoolers from underrepresented groups throughout California.
Celebrating a Future Filled With Discoveries and Cures
Honoring the scientists who will change the world and T. Denny Sanford for making it all possible. October 21, 2023 at Estancia La Jolla. Join us!
Join Honorary Co-Chairs, Roberta and Malin Burnham, for this special Gala to celebrate our incredibly exciting new trajectory as an Institute as we recruit the best scientists from the best labs and institutions in the world to discover new treatments and cures.